Item 2.02 Results of Operations and Financial Condition

On August 10, 2020, Zynerba Pharmaceuticals, Inc. (the "Company") issued a press release announcing its financial results and operational highlights for the second quarter ended June 30, 2020. A copy of this press release is furnished as Exhibit 99.1 hereto.

The information furnished pursuant to this Item 2.02, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.




Item 8.01 Other Events

Attached as Exhibit 99.2 is a presentation, including certain financial information that the Company will post on its website on August 10, 2020 and may use from time to time in presentations or discussions with investors, analysts or other parties.

Item 9.01 Financial Statements and Exhibits

The following exhibit is being filed herewith:





(d) Exhibits



Exhibit
No.                            Document

  99.1       Press Release, dated August 10, 2020.*
  99.2       Zynerba Pharmaceuticals, Inc. Presentation.**




* Furnished herewith

** Filed herewith

© Edgar Online, source Glimpses